Title
Author
DOI
Article Type
Special Issue
Volume
Issue
Endometrial stromal nodule: report of 8 cases and literature review
1Laboratory of Gynecologic Oncology, Fujian Maternity and Child Health Hospital, Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China
2Department of Gynecology, Fujian Maternity and Child Health Hospital, Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China
3Department of Radiology, Fujian Maternity and Child Health Hospital, Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China
DOI: 10.31083/j.ejgo.2020.03.5039 Vol.41,Issue 3,June 2020 pp.332-338
Submitted: 11 October 2018 Accepted: 25 February 2019
Published: 15 June 2020
*Corresponding Author(s): P.M. Sun E-mail: smabuchi@gyne.med.osaka-u.ac.jp
Endometrial stromal nodule (ESN) is a rare and benign tumor of endometrial stromal origin that accounts for less than 10% of uterine mesenchymal neoplasms. It is difficult and yet essential to preoperatively differentiate endometrial stromal nodule from other types of mesenchymal malignancies, considering that the therapeutic options and clinical outcomes are totally different. To better guide clinical practice, the authors herein report eight cases diagnosed with endometrial stromal nodule and analyze the clinical and pathological characteristics, and also perform a literature review of endometrial stromal nodule. Authors of the present study conclude that conservative surgery with fertility-sparing is feasible for a suspected diagnosis of endometrial stromal nodule when ultrasonography suggests hypoechoic masses with cystic degeneration or liquefaction and magnetic resonance imaging showed a well circumscribed mass exhibiting isointensity on T1-weighted images, hyperintensity on T2-weighted images, and hyperintensity on diffusion-weighted images.
Endometrial stromal nodule; Literature review; Magnetic resonance imaging; Fertility sparing; Treatment
J. An, G. Ruan, X.Y. Xie, Y.Q. Shi,X.D. Mao, B.H. Dong, P.M. Sun. Endometrial stromal nodule: report of 8 cases and literature review. European Journal of Gynaecological Oncology. 2020. 41(3);332-338.
[1] Silverberg S.G.: “Tumorlike lesions. Tumors of the uterine corpus and gestational trophoblastic disease”. In: Atlas of Tumor Pathology. Arm Forces Institute of Pathology, 1992, 191.
[2] Carcangiu M.L., Herrington., Kurman R.J.: “WHO Classification of Tumours of the Female Reproductive Organs”. 2010.
[3] Dionigi A., Oliva E., Clement P.B., Young R.H.: “Endometrial stro mal nodules and endometrial stromal tumors with limited infiltra tion: a clinicopathologic study of 50 cases”. Am. J. Surg. Pathol., 2002, 26, 567.
[4] Tavassoli F.A., Norris H.J.: “Mesenchymal tumours of the uterus. VII. A clinicopathological study of 60 endometrial stromal nodules”. Histopathology, 1981, 5, 1.
[5] Oliva E., Young R.H., Clement P.B., Bhan A.K., Scully R.E.: “Cellular benign mesenchymal tumors of the uterus. A comparative morphologic and immunohistochemical analysis of 33 highly cellular leiomyomas and six endometrial stromal nodules, two frequently confused tumors”. Am. J. Surg. Pathol., 1995, 19, 757.
[6] Horng H.C., Wen K.C., Wang P.H., Chen Y.J., Yen M.S., Ng H.T.: “Uterine sarcoma Part IIUterine endometrial stromal sarcoma: The TAG systematic review”. Taiwan J. Obstet. Gynecol., 2016, 55, 472.
[7] Schilder J.M., Hurd W.W., Roth L.M., Sutton G.P.: “Hormonal treatment of an endometrial stromal nodule followed by local excision”. Obstet. Gynecol., 1999, 93, 805.
[8] Norris H.J., Taylor H.B.: “Mesenchymal tumors of the uterus. A clinical and pathological study of 53 endometrial stromal tumors”. Cancer, 1966, 19, 755.
[9] Hart W.R., Yoonessi M.: “Endometrial stromatosis of the uterus”. Obstet. Gynecol., 1977, 49, 393.
[10] Fekete P.S., Vellios F.: “The clinical and histologic spectrum of endometrial stromal neoplasms: a report of 41 cases”. Int. J. Gynecol. Pathol., 1984, 3, 198.
[11] Chang K.L., Crabtree G.S., LimTan S.K., Kempson R.L., Hendrickson M.R.: “Primary uterine endometrial stromal neoplasms. A clinicopathologic study of 117 cases”. Am. J. Surg. Pathol., 1990, 14, 415.
[12] Press M.F., Scully R.E.: “Endometrial “sarcomas” complicating ovarian thecoma, polycystic ovarian disease and estrogen therapy”. Gynecol. Oncol., 1985, 21, 135.
[13] Altaras M.M., Jaffe R., Cohen I., Gruber A., YanaiInbar I., Bernheim J.: “Role of prolonged excessive estrogen stimulation in the pathogenesis of endometrial sarcomas: two cases and a review of the literature”. Gynecol. Oncol., 1990, 38, 273.
[14] Eddy G.L., Mazur M.T.: “Endolymphatic stromal myosis associated with tamoxifen use”. Gynecol. Oncol., 1997, 64, 262.
[15] Chiang S., Ali R., Melnyk N., Mcalpine J.N., Huntsman D.G., Gilks C. B., et al.: “Frequency of known gene rearrangements in endometrial stromal tumors”. Am. J. Surg. Pathol., 2011, 35, 1364.
[16] Tokinaga A., Furuya M., Niino H., Udaka N., Asaisato M., Sekido H., Miyagi E.: “Colonic lowgrade endometrial stromal sarcoma and orthotopic endometrial stromal tumor with limited infiltration sharing the JAZFISUZ12 gene fusion”. Pathol Int. 2014, 64, 178.
[17] Agoff S.N., Grieco V.S., Garcia R., Gown A.M.: “Immunohisto chemical distinction of endometrial stromal sarcoma and cellular leiomyoma”. Appl. Immunohistochem. Mol. Morphol., 2001, 9, 164.
[18] Rush D.S., Tan J., Baergen R.N., Soslow R.A.: “hCaldesmon, a novel smooth musclespecific antibody, distinguishes between cellular leiomyoma and endometrial stromal sarcoma”. Am. J. Surg. Pathol., 2001, 25, 253.
[19] McCluggage W.G., Sumathi V.P., Maxwell P.: “CD10 is a sensitive and diagnostically useful immunohistochemical marker of normal endometrial stroma and of endometrial stromal neoplasms”. Histopathology., 2001, 39, 273.
[20] Zhu X.Q., Shi Y.F., Cheng X.D., Zhao C.L., Wu Y.Z.: “Immunohistochemical markers in differential diagnosis of endometrial stromal sarcoma and cellular leiomyoma”. Gynecol. Oncol., 2004, 92, 71.
[21] Kir G., Cetiner H., Karateke A., Gurbuz A., Bulbul D.: “Utility of MIB1 and estrogen and progesterone receptor in distinguishing between endometrial stromal sarcomas and endometrial stromal nodules, highly cellular leiomyomas”. Int. J. Gynecol. Cancer, 2005, 15, 337.
[22] De L.L., Waltregny D., Boniver J., Young R.H., Castronovo V., Oliva E.: “Use of histone deacetylase 8 (HDAC8), a new marker of smooth muscle differentiation, in the classification of mesenchymal tumors of the uterus”. Am. J. Surg. Pathol., 2006, 30, 319.
[23] Parraherran C.E., Yuan L., Nucci M.R., Quade B.J.: “Targeted development of specific biomarkers of endometrial stromal cell differentiation using bioinformatics: the IFITM1 model”. Mod. Pathol., 2013, 27, 569.
[24] Stemme S., Ghaderi M., Carlson J.W.: “Diagnosis of endometrial stromal tumors: a clinicopathologic study of 25 biopsy specimens with identification of problematic areas”. Am. J. Clin. Pathol., 2014, 141, 133.
[25] Borg C.S., Humaidan P., Noer H., Majeed H.G.: “Endometrial Stromal Nodule: A Rarity and a Pathological Challenge”. Case. Rep. Obstet. Gynecol., 2015, 2015, 376817.
[26] Maruyama S., Sato Y., Satake Y., Mise H., Kim T.: “DiffusionWeighted MRI and FDGPET in Diagnosis of Endometrial Stromal Nodule”. Case. Rep. Obstet. Gynecol., 2015, 2015, 540283.
[27] Ozaki K., Gabata T.: “Magnetic resonance imaging of an endometrial stromal nodule”. J. Obstet. Gynaecol. Res., 2016, 42, 99.
[28] Tamai K., Koyama T., Saga T., Morisawa N., Fujimoto K., Mikami Y., Togashi K.: “The utility of diffusionweighted MR imaging for differentiating uterine sarcomas from benign leiomyomas”. Eur. Radiol., 2008, 18, 723.
[29] Jin Y., Li Y., Deng C.Y., Tian Q.J., Chen H., Pan L.Y.: “Fertilitysparing treatment of lowgrade endometrial stromal sarcoma”. Int. J. Clin. Exp. Med., 2015, 8, 5818.
[30] Bai H., Yang J., Cao D., Huang H., Xiang Y., Wu M., Cui Q., et al.: “Ovary and uterussparing procedures for lowgrade endometrial stromal sarcoma: a retrospective study of 153 cases”. Gynecol. Oncol., 2014, 132, 654.
Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.
Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.
Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.
JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.
Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.
BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.
Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.
Top